384 related articles for article (PubMed ID: 18242020)
21. Amorphous-state characterization of efavirenz--polymer hot-melt extrusion systems for dissolution enhancement.
Sathigari SK; Radhakrishnan VK; Davis VA; Parsons DL; Babu RJ
J Pharm Sci; 2012 Sep; 101(9):3456-64. PubMed ID: 22437488
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs.
Van den Mooter G; Weuts I; De Ridder T; Blaton N
Int J Pharm; 2006 Jun; 316(1-2):1-6. PubMed ID: 16563676
[TBL] [Abstract][Full Text] [Related]
23. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
[TBL] [Abstract][Full Text] [Related]
24. Application and functional characterization of POVACOAT, a hydrophilic co-polymer poly(vinyl alcohol/acrylic acid/methyl methacrylate) as a hot-melt extrusion carrier.
Xu M; Zhang C; Luo Y; Xu L; Tao X; Wang Y; He H; Tang X
Drug Dev Ind Pharm; 2014 Jan; 40(1):126-35. PubMed ID: 23336809
[TBL] [Abstract][Full Text] [Related]
25. Understanding the performance of melt-extruded poly(ethylene oxide)-bicalutamide solid dispersions: characterisation of microstructural properties using thermal, spectroscopic and drug release methods.
Abu-Diak OA; Jones DS; Andrews GP
J Pharm Sci; 2012 Jan; 101(1):200-13. PubMed ID: 21905037
[TBL] [Abstract][Full Text] [Related]
26. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L
Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810
[TBL] [Abstract][Full Text] [Related]
27. Poly(ethylene glycol) layered silicate nanocomposites for retarded drug release prepared by hot-melt extrusion.
Campbell K; Craig DQ; McNally T
Int J Pharm; 2008 Nov; 363(1-2):126-31. PubMed ID: 18657600
[TBL] [Abstract][Full Text] [Related]
28. Systems biology approach to study permeability of paracetamol and its solid dispersion.
Khan S; Elshaer A; Rahman AS; Hanson P; Perrie Y; Mohammed AR
Int J Pharm; 2011 Sep; 417(1-2):272-9. PubMed ID: 21187133
[TBL] [Abstract][Full Text] [Related]
29. New investigation of distribution imaging and content uniformity of very low dose drugs using hot-melt extrusion method.
Park JB; Kang CY; Kang WS; Choi HG; Han HK; Lee BJ
Int J Pharm; 2013 Dec; 458(2):245-53. PubMed ID: 24157343
[TBL] [Abstract][Full Text] [Related]
30. Study of the phase behavior of polyethylene glycol 6000-itraconazole solid dispersions using DSC.
Wang X; Michoel A; Van den Mooter G
Int J Pharm; 2004 Mar; 272(1-2):181-7. PubMed ID: 15019081
[TBL] [Abstract][Full Text] [Related]
31. Enhanced in vivo absorption of CB-1 antagonist in rats via solid solutions prepared by hot-melt extrusion.
Ranzani LS; Font J; Galimany F; Santanach A; Gomez-Gomar AM; Casadevall G; Gryczke A
Drug Dev Ind Pharm; 2011 Jun; 37(6):694-701. PubMed ID: 21226628
[TBL] [Abstract][Full Text] [Related]
32. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
[TBL] [Abstract][Full Text] [Related]
33. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
Patil MP; Gaikwad NJ
Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
[TBL] [Abstract][Full Text] [Related]
34. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling.
Patterson JE; James MB; Forster AH; Lancaster RW; Butler JM; Rades T
Int J Pharm; 2007 May; 336(1):22-34. PubMed ID: 17174493
[TBL] [Abstract][Full Text] [Related]
35. Preparation of carbamazepine-Soluplus solid dispersions by hot-melt extrusion, and prediction of drug-polymer miscibility by thermodynamic model fitting.
Djuris J; Nikolakakis I; Ibric S; Djuric Z; Kachrimanis K
Eur J Pharm Biopharm; 2013 May; 84(1):228-37. PubMed ID: 23333900
[TBL] [Abstract][Full Text] [Related]
36. Preparation of a solid dispersion of felodipine using a solvent wetting method.
Kim EJ; Chun MK; Jang JS; Lee IH; Lee KR; Choi HK
Eur J Pharm Biopharm; 2006 Oct; 64(2):200-5. PubMed ID: 16750355
[TBL] [Abstract][Full Text] [Related]
37. A study of the changes during heating of paracetamol.
de Wet FN; Gerber JJ; Lötter AP; van der Watt JG; Dekker TG
Drug Dev Ind Pharm; 1998 May; 24(5):447-53. PubMed ID: 9876607
[TBL] [Abstract][Full Text] [Related]
38. In-line NIR spectroscopy for the understanding of polymer-drug interaction during pharmaceutical hot-melt extrusion.
Saerens L; Dierickx L; Quinten T; Adriaensens P; Carleer R; Vervaet C; Remon JP; De Beer T
Eur J Pharm Biopharm; 2012 May; 81(1):230-7. PubMed ID: 22269939
[TBL] [Abstract][Full Text] [Related]
39. Application of film-casting technique to investigate drug-polymer miscibility in solid dispersion and hot-melt extrudate.
Parikh T; Gupta SS; Meena AK; Vitez I; Mahajan N; Serajuddin AT
J Pharm Sci; 2015 Jul; 104(7):2142-52. PubMed ID: 25917333
[TBL] [Abstract][Full Text] [Related]
40. Comparative study of the stability of venlafaxine hydrochloride sustained-release pellets prepared by double-polymer coatings and hot-melt subcoating combined with Eudragit(®) NE30D outercoating.
Guan T; Wang J; Li G; Tang X
Pharm Dev Technol; 2011 Jun; 16(3):269-77. PubMed ID: 20214529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
